Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis

Journal of Virology

Volumn 75, Issue 11, 2001, Pages 5302-5314

  Yen, Andrew ^a   Placanica, Lisa ^a   Bloom, Stephen ^a   Varvayanis, Susi ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD11B ANTIGEN; GENE PRODUCT; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; VIRUS SMALL T ANTIGEN;

AEROBIC METABOLISM; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ANTIGENS, VIRAL, TUMOR; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; G0 PHASE; HL-60 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; PHOSPHORYLATION; POLYOMAVIRUS; RECEPTORS, RETINOIC ACID; RETINOBLASTOMA PROTEIN; TRANSFECTION; TRETINOIN;

EID: 0035038396     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.11.5302-5314.2001     Document Type: Article

References (56)

1. Asselin, C., C. Gelinas, and M. Bastin. 1983. Role of the three polyomavirus early proteins in tumorigenesis. Mol. Cell Biol. 3:1451-1459.
2. Asselin, C., J. Vass-Marengo, and M. Bastin. 1986. Mutation in the polyomavirus genome that activates the properties of large T associated with neoplastic transformation. J. Virol. 57:165-172.
3. Battle, T., R. A. Levine, and A. Yen. 2000. Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells. Exp. Cell Res. 254:287-298.
4. Battle, T. E., M. S. Roberson, T. Zhang, S. Varvayanis, and A. Yen. 2000. Retinoic acid-induced blr1 expression requires RARα, RXR, and MAPK activation and uses ERK2 hut not JNK/SAPK to accelerate cell differentiation. Eur. J. Cell Biol. 80:59-67.
5. Berger, H., and E. Wintersberger. 1986. Polyomavirus small T antigen enhances replication of viral genomes in 3T6 mouse fibroblasts. J. Virol. 60: 768-770.
6. Bergqvist, A., K. Söderbärg, and G. Magnusson. 1997. Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens. J. Virol. 71:276-283.
7. Breitman, T. R., S. E. Selonick, and S. J. Collins. 1987. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77:2936-2940.
8. 1-restricted growth arrest of NB4 cells. Exp. Cell Res. 234:259-269.
9. Brooks, S. C., III, S. Kazmer, A. A. Levin, and A. Yen. 1996. Myeloid differentiation and RB phosphorylation changes in HL-60 cells induced by RAR- and RXR-selective retinoic acid analogs. Blood 87:227-237.
10. Cepko, C. L., B. E. Roberts, and R. C. Mulligan. 1984. Construction and application of a highly transmissible murine retrovirus shuttle vector. Cell 37:1053-1062.
11. Chamberlin, H. M., and P. W. Sternberg. 1995. Mutations in the Caenorhabditis elegans gene vab-3 reveal distinct rules in fate specification and unequal cytokinesis in an asymmetric cell division. Dev. Biol. 170:679-689.
12. Chen, Y., R. Freund, M. Listerud, Z. Wang, and D. A. Talmage. 1999. Retinoic acid inhibits transformation by preventing phosphatidylinositol 3-kinase dependent activation of the c-fos promoter. Oncogene 18:139-148.
13. Cohen, B., Y. Liu, B. Druker, T. M. Roberts, and B. S. Schaffhausen. 1990. Characterization of pp85, a target of oncogenes and growth factor receptors. Mol. Cell. Biol. 10:2909-2915.
14. Cohen, P. 1989. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58:453-508.
15. Collins, S. J., R. C. Gallo, and R. E. Gallagher. 1977. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270:347-349.
16. Cooper, G. M. 1995. Oncogenes, 2nd ed. Jones and Bartlett, Boston, Mass.
17. 60c-stc. EMBO J. 3:585-591.
18. Gaub, M. P., C. Rochette-Egy, Y. Lutz, S. Ali, H. Matthes, I. Schever, and P. Chambon. 1992. Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp. Cell Res. 201:335-346.
19. Hendrix, P., P. M. Turowski, R. E. Mayer-Jackel, J. Goris, J. Hofsteenge, W. Merlevede, and B. A. Hemmings. 1993. Analysis of subunit isoforms in protein phosphatase 2A holoenzymes from rabbit and Xenopus. J. Biol. Chem. 268:7330-7337.
20. Holman, P. S., O. V. Gjoerup, T. Davin, and B. S. Schaffhausen. 1994. Characterization of an immortalizing N-terminal domain of polyomavirus large T antigen. J. Virol. 68:668-673.
21. Howe, A. K., S. Gaillard, J. S. Bennett, and K. Rundell. 1998. Cell cycle progression in monkey cells expressing simian virus 40 small t antigen from adenovirus vectors. J. Virol. 72:9637-9644.
22. Kamibayashi, C., R. Estes, C. Slaughter, and M. C. Mumby. 1991. Subunit interactions control protein phosphatase 2A: effect of limited proteolysis, n-ethylmaleimide, and heparin on the interaction of the B subunit. J. Biol. Chem. 266:13251-13260.
23. Knoblich, J. A., L. Y. Jan, and Y. N. Jan. 1999. Deletion analysis of the Drosophila Inscuteable protein reveals domains for cortical localization and asymmetric localization. Curr. Biol. 9:155-158.
24. Kolzau, T., R. S. Hansen, D. Zahra, R. R. Reddel, and A. W. Braithwaite. 1999. Inhibition of SV40 large T antigen induced apoptosis by small T antigen. Oncogene 18:5598-5603.
25. Lebrin, F., L. Bianchini, T. Rabilloud, E. M. Chambaz, and Y. Goldberg. 1999. CK2α-protein phosphatase 2A molecular complex: possible interaction with the MAP kinase pathway. Mol. Cell. Biochem. 191:207-212.
26. Lefebvre, P., M. P. Gaub, A. Tahayato, C. Rochette-Egly, and P. Formstecher. 1995. Protein phosphatases 1 and 2A regulate the transcriptional and DNA binding activities of retinoic acid receptors. J. Biol. Chem. 270: 10806-10816.
27. Lewis, P. J., S. R. Partridge, and J. Errington. 1994. σ factors, asymmetry, and the determination of cell fate in Bacillus subtilis. Proc. Natl. Acad. Sci. USA 91:3849-3853.
28. Losick, R., and J. Dworkin. 1999. Linking asymmetric division to cell fate: teaching an old microbe new tricks. Genes Dev. 13:377-381.
29. Marczynski, G. T., and L. Shapiro. 1995. The control of asymmetric gene expression during Caulobacter cell differentiation. Arch. Microbiol. 163:313-321.
30. Morita, K., M. Nishikawa, K. Kobayashi, K. Deguchi, M. Ito, T. Nakano, H. Shima, M. Nagao, T. Kuno, C. Tanaka, et al. 1992. Augmentation of retinoic acid-induced granulocytic differentiation in HL-60 leukemia cells by serine/ threonine protein phosphatase inhibitors. FEBS Lett. 314:340-344.
31. Mullane, K. P., M. Ratnofsky, X. Cullere, and B. Schaffhausen. 1998. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A. Mol. Cell. Biol. 18:7556-7564.
32. Mumby, M. C., and G. Walter. 1993. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol. Rev. 73:673-699.
33. Muscarella, D. E., M. K. Rachlinski, J. Sotiriadis, and S. E. Bloom. 1998. Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells. Exp. Cell Res. 238:155-167.
34. Nishikawa, M., S. B. Omay, H. Toyoda, I. Tawara, H. Shima, M. Nagao, B. A. Hemmings, M. C. Mumby, and K. Deguchi. 1994. Expression of the catalytic and regulatory subunits of protein phosphatase type 2A may be differentially modulated during retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res. 54:4879-4884.
35. Ogris, E., I. Mudrak, and E. Wintersberger. 1992. Polyomavirus large and small T antigens cooperate in induction of the S phase in serum-starved 3T3 mouse fibroblasts. J. Virol. 66:53-61.
36. Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle-T antigens and SV40 small T antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.
37. Platko, J. D., M. E. Forbes, S. Varvayanis, M. N. Williams, S. C. Brooks III, V. Cherington, and A. Yen. 1998. Polyoma middle T antigen in HL-60 cells accelerates hematopoietic myeloid cell differentiation. Exp. Cell Res. 238: 42-50.
38. Roder, H. M., F. J. Hoffman, and W. Schroeder. 1995. Phosphatase resistance of ERK2 brain kinase PK40-34K2. J. Neurochem. 64:2203-2212.
39. Sontag, E., S. Fedorov, C. Kamibayashi, D. Robbins, M. Cobb, and M. Mumby. 1993. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75:887-897.
40. Su, W., W. Liu, B. S. Schaffhausen, and T. M. Roberts. 1995 Association of polyomavirus middle tumor antigen with phospholipase C-γ 1. J. Biol. Chem. 270:12331-12334.
41. Wang, Q., and K. G. Wiman. 2000. Polyoma virus middle T and small T antigens cooperate to antagonize p53-induced cell cycle arrest and apoptosis. Cell Growth Differ. 11:31-39.
42. Weinberg, R. 1989. Oncogenes and the molecular origins of cancer, p. 223-238. In W. Eckhart (ed.), Oncogenes of DNA tumor viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Yen, A. 1990. HL-60 cells as a model of growth control and differentiation: the significance of variant cells. Hematol. Rev. 4:5-46.
44. 1 from their high serum requirement. Exp. Cell Res. 116:103-111.
45. Yen, A., and M. E. Forbes. 1990. C-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine. Cancer Res. 50:1411-1420.
46. 2 during the process of induced cell differentiation. Exp. Cell Res. 214:250-257.
47. Yen, A., D. Brown, and J. Fishbaugh. 1987. Precommitment states induced during HL-60 myeloid differentiation: possible similarities of retinoic acid and DMSO induced early events. Exp. Cell Res. 173:80-84.
48. Yen, A., M. Forbes, G. deGala, and J. Fishbaugh. 1987. Control of HL-60 cell differentiation lineage specificity: a late event occurring after precommitment. Cancer Res. 47:129-134.
49. Yen, A., M. E. Forbes, S. Varvayanis, M. L. Tykocinski, R. K. Groger, and J. D. Platko. 1993. C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J. Cell. Physiol. 157:379-391.
50. Yen, A., M. S. Roberson, and S. Varvayanis. 1999. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell. Dev. Biol. Anim. 35:527-532.
51. Yen, A., M. S. Roberson, S. Varvayanis, and A. T. Lee. 1998. Retinoic acid induces mitogen-activated protein (MAP) extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res. 58:3163-3172.
52. Yen, A., R. Sturgill, and S. Varvayanis. 1997. Increasing c-FMS expression decreases retinoic acid concentration needed to cause cell differentiation and RB hypophosphorylation. Cancer Res. 57:2020-2028.
53. 0 arrest is. In Vitro Cell. Dev. Biol. Anim. 36:249-255.
54. 1 arrest and cell differentiation. Exp. Cell Res. 229:111-125.
55. Yen, A., S. L. Reece, and K. L. Albright. 1984. Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: pre-commitment memory associated with altered nuclear structure. J. Cell. Physiol. 118:227-286.
56. Yen, A., V. Cherington, B. Schaffhausen, K. Marks, and S. Varvayanis. 1999. Transformation defective polyoma middle T antigen mutants defective in PLCy, P1-3 or SRC kinase activation enhance ERK2 activation and promote retinoic acid-induced cell differentiation like wild type middle. T. Exp. Cell Res. 248:538-551.